Equity Overview
Price & Market Data
Price: $0.34
Daily Change: $0.00 / 0.00%
Range: $0.34 - $0.40
Market Cap: $840,799
Volume: 8,287
Performance Metrics
1 Week: 14.29%
1 Month: 10.34%
3 Months: -80.12%
6 Months: -99.79%
1 Year: -100.00%
YTD: -99.82%
Company Details
Employees: 39
Sector: Health technology
Industry: Biotechnology
Country: United Kingdom
Details
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.